| 000 | 02583 a2200721 4500 | ||
|---|---|---|---|
| 005 | 20250518055042.0 | ||
| 264 | 0 | _c20200609 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1879-0852 | ||
| 024 | 7 |
_a10.1016/j.ejca.2019.06.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRobson, Mark | |
| 245 | 0 | 0 |
_aPatient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _c10 2019 |
||
| 300 |
_a20-30 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
| 650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCapecitabine _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aFurans _xadministration & dosage |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Agencies |
| 650 | 0 | 4 |
_aKetones _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPatient Reported Outcome Measures |
| 650 | 0 | 4 |
_aPhthalazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime-to-Treatment |
| 650 | 0 | 4 |
_aVinorelbine _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aRuddy, Kathryn J | |
| 700 | 1 | _aIm, Seock-Ah | |
| 700 | 1 | _aSenkus, Elżbieta | |
| 700 | 1 | _aXu, Binghe | |
| 700 | 1 | _aDomchek, Susan M | |
| 700 | 1 | _aMasuda, Norikazu | |
| 700 | 1 | _aLi, Wei | |
| 700 | 1 | _aTung, Nadine | |
| 700 | 1 | _aArmstrong, Anne | |
| 700 | 1 | _aDelaloge, Suzette | |
| 700 | 1 | _aBannister, Wendy | |
| 700 | 1 | _aGoessl, Carsten | |
| 700 | 1 | _aDegboe, Arnold | |
| 700 | 1 | _aHettle, Robert | |
| 700 | 1 | _aConte, Pierfranco | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 120 _gp. 20-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2019.06.023 _zAvailable from publisher's website |
| 999 |
_c30038409 _d30038409 |
||